GSK gains after positive results for two lung cancer drugs
14/09/2026 08:25
BUZZ-GSK gains after positive results for two lung cancer drugs
** Shares of British pharmaceutical company GSK GSK.L rise 2.5% to 1,815p
** Co's lung cancer drug Jideytro met its main goal, with complete or partial tumour shrinkage in 94% patients
** Co also reports positive late-stage data showing Ris-Rez (licensed from Hansoh Pharmaceutical 3692.HK) cut the risk of death by 54% vs standard chemotherapy in relapsed small cell lung cancer
** As of last close, stock down 2.96% YTD
(Reporting by Anushka Chourasia in Bengaluru)